Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early changes in renal function following chemically induced nephropathy.

M F Wilks, B Schmidt-Nielsen, H Stolte

    Clinical Physiology and Biochemistry
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.

    Nanotoxicology·2018
    Same author

    White paper on the promotion of an integrated risk assessment concept in European regulatory frameworks for chemicals.

    The Science of the total environment·2015
    Same author

    Bisphenol A--Why an adverse outcome pathway framework needs to be applied.

    Toxicology letters·2014
    Same author

    Neurodevelopmental and neurobehavioural effects of polybrominated and perfluorinated chemicals: a systematic review of the epidemiological literature using a quality assessment scheme.

    Toxicology letters·2014
    Same author

    With the benefit of hindsight: trials using retrospective controls versus randomized controlled trials in clinical toxicology.

    Clinical toxicology (Philadelphia, Pa.)·2013
    Same author

    Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis.

    The Science of the total environment·2013

    Early kidney damage from 2-bromoethanamine hydrobromide (BEA) involves tubular and glomerular dysfunction. BEA significantly increases urine flow and urea excretion within 30 minutes, indicating rapid nephropathy.

    Area of Science:

    • Nephrology
    • Toxicology
    • Renal Physiology

    Background:

    • 2-bromoethanamine hydrobromide (BEA) is known to cause kidney damage.
    • Limited data exists on the early functional alterations induced by BEA.

    Purpose of the Study:

    • To investigate early functional changes in rat kidneys following BEA administration.
    • To elucidate the pathomechanisms of BEA-induced nephropathy.

    Main Methods:

    • Wistar rats were injected with BEA (100 mg/kg BW) or sham-injected.
    • Renal function was assessed within the first 3 hours post-injection.
    • Measurements included urine flow, osmolality, electrolytes, urea, and clearance of inulin and para-aminohippuric acid (PAH).

    Main Results:

    Related Experiment Videos

    • Significantly increased urine flow and urea excretion observed within 30 minutes.
    • Decreased urine osmolality after 90 minutes and elevated sodium excretion at 3 hours.
    • Progressively decreasing glomerular filtration rate and PAH clearance during the initial 3 hours.

    Conclusions:

    • BEA induces early alterations in both tubular and glomerular kidney function.
    • BEA affects tubular sodium handling, papillary concentrating capacity, and glomerular filtration.
    • These findings clarify the early pathomechanisms of BEA-induced nephropathy.